KERYX BIOPHARMACEUTICALS INC 4
4 · KERYX BIOPHARMACEUTICALS INC · Filed Jun 18, 2015
Insider Transaction Report
Form 4
Regan Daniel Paul
Director
Transactions
- Award
Common Stock
2015-06-17+10,000→ 30,000 total - Award
Stock Option (right to buy)
2015-06-17+30,000→ 30,000 totalExercise: $9.95From: 2016-06-17Exp: 2025-06-17→ Common Stock (30,000 underlying)
Footnotes (3)
- [F1]The 10,000 shares are restricted common stock, with one-third of the 10,000 shares vesting on each of June 17, 2016, June 17, 2017 and June 17, 2018.
- [F2]Includes 26,666 shares of restricted stock.
- [F3]The 30,000 stock options vest as to one-third on each of June 17, 2016, June 17, 2017 and June 17, 2018.